According to Dermapharm's latest financial reports the company's current earnings (TTM) are $0.22 B. In 2022 the company made an earning of $0.24 B a decrease over its 2021 earnings that were of $0.35 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.22 B | -6.21% |
2022 | $0.24 B | -31.28% |
2021 | $0.35 B | 123.6% |
2020 | $0.15 B | 15.62% |
2019 | $0.13 B | 4.32% |
2018 | $0.12 B | 19.21% |
2017 | $0.10 B |